Skip to main content
BMC Complementary and Alternative Medicine logoLink to BMC Complementary and Alternative Medicine
. 2013 Jul 27;13:193. doi: 10.1186/1472-6882-13-193

Immunomodulatory role of Emblica officinalis in arsenic induced oxidative damage and apoptosis in thymocytes of mice

Manish K Singh 1, Suraj S Yadav 1, Vineeta Gupta 1, Sanjay Khattri 1,
PMCID: PMC3733846  PMID: 23889914

Abstract

Background

Arsenic is widely distributed in the environment and has been found to be associated with the various health related problems including skin lesions, cancer, cardiovascular and immunological disorders. The fruit extract of Emblica officinalis (amla) has been shown to have anti-oxidative and immunomodulatory properties. In view of increasing health risk of arsenic, the present study has been carried out to investigate the protective effect of amla against arsenic induced oxidative stress and apoptosis in thymocytes of mice.

Methods

Mice were exposed to arsenic (sodium arsenite 3 mg/kg body weight p.o.) or amla (500 mg/kg body weight p.o.) or simultaneously with arsenic and amla for 28 days. The antioxidant enzyme assays were carried out using spectrophotometer and generation of ROS, apoptotic parameters, change in cell cycle were carried out using flow cytometer following the standard protocols.

Results

Arsenic exposure to mice caused a significant increase in the lipid peroxidation, ROS production and decreased cell viability, levels of reduced glutathione, the activity of superoxide dismutase, catalase, cytochrome c oxidase and mitochondrial membrane potential in the thymus as compared to controls. Increased activity of caspase-3 linked with apoptosis assessed by the cell cycle analysis and annexin V/PI binding was also observed in mice exposed to arsenic as compared to controls. Co-treatment with arsenic and amla decreased the levels of lipid peroxidation, ROS production, activity of caspase-3, apoptosis and increased cell viability, levels of antioxidant enzymes, cytochrome c oxidase and mitochondrial membrane potential as compared to mice treated with arsenic alone.

Conclusions

The results of the present study exhibits that arsenic induced oxidative stress and apoptosis significantly protected by co-treatment with amla that could be due to its strong antioxidant potential.

Keywords: Arsenic, Emblica officinalis, Oxidative stress, Apoptosis, Thymocytes

Background

Arsenic is considered as an environmental contaminant and widely distributed in the environment due to its natural existence and anthropogenic applications [1,2]. It has long been used in pharmaceuticals, glass industries, manufacturing of sheep-dips, leather preservatives, poisonous baits, pesticides and semiconductor devices [3-5]. Exposure to arsenic in human could occur through air, soil and other occupational sources [6]. Human exposure to arsenic through contaminated food materials is quite common in the area having high levels of arsenic in ground water [6-8]. High levels of arsenic in ground water in India and many other regions of the world have been found to be associated with various health related problems including arsenicosis, skin lesions, cardiovascular diseases, reproductive problems, psychological, neurological and immunotoxic responses [2,9]. In view of increasing risk of arsenic toxicity, World Health Organization lowered the limit of arsenic in ground water from 50 μg/l to 10 μg/l [6].

Epidemiological studies have suggested that exposure to arsenic in humans may attributed to various immune related disorders [10-13]. In utero exposure to arsenic has been shown to suppress the immune mediated cells and impaired child thymic development associated with increased morbidity in children [14]. Exposure to arsenic during pregnancy has been found to lower thymic index suggested poor development of thymus in infants [15]. Increased placental inflammatory response, reduced placental T cells and altered levels of cord blood cytokines linked with fetal death, impaired infant health associated with enhanced oxidative stress have also been reported following exposure to arsenic [16,17]. Andrew et al. [10] observed that arsenic exposure may stimulate the over expression of genes involved in the defense system, immune function, cell growth, apoptosis, regulation of cell cycle, T cell receptor signaling pathway and diabetes. Association of arsenic intoxication with cancer, black foot disease and diabetes has also been reported [18,19]. Arsenic exposure in mice has been found to be associated with the increased free radical generation that affects the primary electron rich sites within the cells and cause DNA damage in human lymphocytes [20-22], breaking of DNA strand, DNA base modifications, protein crosslink, structural carbohydrates and lipids [23-25]. Arsenic induced cell death has been strongly linked to the induction of autophagy in human lymphoblastoid cell lines to impart its immunotoxic effects [11,12]. Numerous studies have reported that exposure to inorganic arsenic increased the frequency of micronuclei, chromosome aberrations and sister chromatid exchanges both in humans and experimental animals [26,27].

Recently, plant derived natural compounds and their active constituents have received great attention as a potential antioxidant against arsenic induced toxicity [21,28,29]. The fruit extract of Emblica officinalis (amla) with a history of medicinal value, long been used in Chinese and Indian traditional system of medicine and has shown anti-oxidative and immunomodulatory properties [30-33]. Amla contains a wide variety of phenolics including anthocyanins, flavonols, ellagic acid and its derivatives which protects against the harmful action of ROS and exhibits a wide range of biological effects including antioxidant, anti-tumour, anti-inflammatory, anti-bacterial and hepato-protective [32-34]. The dose of arsenic selected in the present study is quite low and based on the earlier studies [35,36]. Although a number of studies have been carried out to understand the protective efficacy of herbal agents against arsenic induced toxicity, not much is known about its mechanism involved in immunotoxicity and protective management. In recent years, the intake of dietary polyphenols has received a great attention of health scientists to use them in the therapeutic management of various disease conditions. The present study has therefore been focused to investigate the immunomodulatory role of the fruit extract of amla in arsenic induced oxidative damage including lipid peroxidation, status of antioxidant enzymes and mitochondrial membrane potential and apoptosis and necrosis in thymocytes of mice.

Methods

Chemicals

Sodium arsenite, RNase A, 2′,7′-dichlorofluorescein diacetate (DCFH-DA), 3-(4,5-dimethyl-2-yl)- 2,5-diphenyl tetrazolium bromide (MTT), 7-amino-4-trifluoro methylcoumarin (AFC), DPPH (1,1-diphenyl-2-2′-picrylhydrayl) and all other chemicals were purchased from Sigma–Aldrich, USA. Rhodamine 123 (Rh 123) and from Molecular Probes, propidium iodide (PI) from Calbiochem, and Annexin V-FITC were purchased from Biovision.

Plant material

Studies have been reported that phenolics and flavonoids including gallic acid, ellagic acid, isocorilagin, chebulanin and chebulagic acid are the major constituents present in ethyl acetate extract of amla [37,38]. To investigate the combined effect of theses constituents, ethyl acetate extract of amla has been selected for the present study. Briefly, the fresh fruits of amla were collected from authentic source and fruit powder was extracted three times using 95% ethanol (Plant Identification No. - 13394 obtained by the Herbarium of Birbal Sahni Institute of Palaeobotany, Lucknow, India). The combined extracts were filtered and evaporated to dryness with a rotary evaporator under reduced pressure and the residue was suspended in water and extracted successively with diethyl ether and ethyl acetate. The extract was evaporated under reduced pressure to get powdered form of ethyl acetate fraction.

Animals and treatment

The Balb/c male mice (15 ± 2 g) were obtained from the animal breeding colony of CSIR-Indian Institute of Toxicology Research, Lucknow used for the study. Mice were housed in an air-conditioned room at 25 ± 2°C with a 12 h light/dark cycle under standard hygiene conditions and had free access to pellet diet and water ad libitum. The study was approved by the institutional animal ethics committee of King George Medical University, Lucknow (No. 121 IAH/Pharma-11) and all experiments were carried out in accordance with the guidelines laid down by the committee for the purpose of control and supervision of experiments on animals (CPCSEA), Ministry of Environment and Forests (Government of India), New Delhi, India. The animals were randomly divided into four groups contained ten animals in each group as follows

Group I. Mice were treated with vehicle (2% gum acacia) for the duration of the treatment to serve as controls.

Group II. Mice were treated with arsenic as sodium arsenite (dissolved in distilled water 3 mg/kg body weight p.o., daily for 30 days).

Group III. Mice were treated with fruit extract of amla (500 mg/kg body weight, suspended in 2% gum acacia, p.o., daily for 30 days).

Group IV. Mice were co-treated with arsenic and fruit extract of amla identically as in group II and III.

After the last dose of treatment, animals were sacrificed and thymus of all the animals was isolated. Out of all isolated thymus three of each set, put into the phosphate buffer saline (PBS) and processed for the measurement of apoptotic parameters. While remaining thymus were immediately placed in an ice cold saline solution (0.15M), blotted on filter paper, quickly weighed and processed for enzymatic and non-enzymatic antioxidants assays.

Preparation of thymocyte suspension

Thymus was dissected from mice and single cell suspension was prepared under aseptic condition. The suspension was passed through stainless steel mesh centrifuged at 200 × g at 4°C for 10 min and resuspended in complete cell culture medium (RPMI-1640 containing HEPES and 2mM glutamine, supplemented with 10% FBS and 1% antibiotic antimycotic solution) the cell density were adjusted to 1.5 × 106 cell/ml.

Measurement of antioxidant activity

Assay of DPPH radical scavenging activity

The free radical scavenging activity of ethyl acetate extract amla was measured by the scavenging of the DPPH radical using the standard method with slight modifications [39]. Amla extract at different concentrations (1.0, 2.5, 5, 10, 20 and 40 μg/ml) in ethanol (2ml) was mixed with DPPH (2 ml, 1mM in ethanol) and incubated for 30 min in the dark. The absorbance of DPPH radical was read at 517 nm using a spectrophotometer. The DPPH radical scavenging activity was calculated using the following equation

Scavengingactivity%=A0A1/A0×100

where A0 is the absorbance of the control reactions and A1 is the absorbance in the presence of the test compound.

Biochemical parameters

Assessment of cell viability

The cell viability was measured by the MTT reduction method following the standard procedure [40]. Cells were seeded at a density of 1.0 × 104 in a 96 well plate. 10 μl of MTT (5 mg/ml PBS) was added to the each well and incubated for 4 h at 37°C in a CO2 incubator. The plate was centrifuged at 1200 × g for 10 min and 100 μl of DMSO was added after aspirating supernatant to dissolve the formazan formed in the wells. After 5 min the absorbance was read on a microplate reader (Synergy HT of BIO-TEK International, USA) at 530 nm.

Assay of lipid peroxidation

Lipid peroxidation as a measure of thiobarbituric acid reactive substances was measured following the standard procedure [41]. Malondialdehyde (MDA) forms as an intermediate product of the peroxidation of lipids and serves as an index of the intensity of oxidative stress. The intensity of pink color formed during the reaction was read on a spectrophotometer at 532 nm.

Assay of reduced glutathione levels

Levels of reduced glutathione (GSH) in the thymus homogenate were estimated following the standard protocol [42]. The assay involves the reaction of GSH with 5, 5′-dithiobis-2 nitrobenzoic acid (DTNB) that forms yellow color and its absorbance was taken by spectrophotometer at 412 nm. The result has been expressed at μg GSH/mg protein.

Assay of superoxide dismutase activity

Activity of superoxide dismutase in thymus homogenate was assayed according to the method of Marklund and Marklund [43]. The unit of enzyme activity is defined as the enzyme required for 50% inhibition of pyrogallol auto-oxidation. The results have been expressed as unit/min/mg protein.

Assay of catalase activity

Activity of catalase in thymus homogenate was assayed following the standard protocol [44] using hydrogen peroxide (H2O2) as substrate. The activity of catalase was measured on a spectrophotometer and has been expressed in μmole/min/mg protein.

Assay of caspase-3 activity

Activity of caspase-3 in thymocytes was measured following the standard procedure described by Pathak and Khandelwal [45]. Briefly, the cells (3.0 × 106/ml) were lysed on ice for 10 min with the help of lysis buffer. Further, the reaction buffer (10 mM Tris–HCl, 1 mM EDTA, 10 mM DTT, 5% glycerol) and DEVD-AFC substrate (50 μM) were added and incubated at 37°C in dark for 2 h. AFC was used as standard and fluorescence was measured at excitation and emission wavelengths of 400 nm/505 nm, respectively, on a microplate reader. The enzyme activity is expressed as nmoles AFC/60 min.

Assay of cytochrome c oxidase activity

Cytochrome c oxidase activity was assayed through the colorimetric assay kit purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA). Absorbance was measured on a spectrophotometer at 550 nm and values are expressed as U/ml.

Assay of ROS generation

The generation of ROS was measured using DCFH-DA by flow cytometry as described previously [46]. Single cell suspension (1 × 106/ml) of thymus from control and treated mice was suspended in PBS and incubated with DCFH-DA at 37°C for 1 h. Hydrolysis of DCFH-DA leads to formation of fluorescence DCFH that was measured by the fluorescence intensity (FL-1, 530 nm).

Assay of mitochondrial membrane potential

The detection of mitochondrial membrane potential was assessed by flow cytometry following the standard procedure [47]. Single cell suspension (1 × 106/ml) was incubated with Rh-123 for 60 min in dark at 37°C. The mitochondrial membrane potential was measured using FL-1 filter at fluorescence intensity of 530 nm.

Analysis of apoptotic DNA

The assay of apoptotic DNA was carried out using the standard procedure [48]. Briefly, cell suspension of thymocytes at a density of 1 × 106 cells from control and treated mice was prepared for the detection of cell cycle analysis. Cells were washed with PBS and fixed by 70% ethanol. The fixed cells were again washed with PBS and added phosphate citrate buffer (200 μl, pH 7.8) and incubated for 60 min at room temperature. After centrifugation the cells were resuspended in 0.5 ml propidium iodide (PI) and 0.5 ml RNAse (50 μg/ml) and further incubated for 30 min in the dark. The PI fluorescence was measured through a FL-2 filter (585 nm) and a total of 10,000 events were acquired.

Assessment of apoptotic and necrotic cell

The apoptotic and necrotic cell distribution was analyzed through Annexin V binding and PI uptake following the procedure of Vermes et al. [49]. Briefly, thymocytes were suspended in 1 ml binding buffer (1×), an aliquot of 100 μl was incubated with 5 μl Annexin V-FITC and 10 μl PI for 15 min in dark at room temperature and 400 μl binding buffer (1×) was added to each sample, the FITC and PI fluorescence will be measured through FL-1 (530 nm) and FL-2 filters (585 nm) respectively.

Protein estimation

Protein concentration in thymus homogenates was measured following the standard procedure [50] using bovine serum albumin as the reference standard.

Statistical analysis

The statistical analysis was carried out by GraphPad Prism 3.02 using one way analysis of variance followed by Newman–Keuls test for multiple pair wise comparisons among the groups. All values have been expressed as mean ± SEM. P value <0.05 has been considered significant.

Results

Effect on DPPH free radical scavenging activity

The different concentration of ethyl acetate extract of amla (1.0, 2.5, 5 10, 20 and 40 μg/ml) in ethanol (2 ml) was used for the DPPH radical scavenging activity and results were presented in Figure 1. The 50% inhibitory concentration (IC50) of fruit extract was found to be 8.32 μg/ml and it become saturated over 20 μg/ml concentration where the activity was more than 90%. The results showed that ethyl acetate extract of amla has strong free radical scavenging activity associated with its antioxidant potential.

Figure 1.

Figure 1

DPPH free radical scavenging activity of fruit extract of Emblica officinalis. The concentration of extract above 20 μg/ml showed a saturation in the plot indicating the radical scavenging activity of more than 90%.

Effect on body weight and thymus weight in mice

Effect of arsenic and co-treatment of arsenic and amla on mice has been presented in Table 1. Exposure to arsenic in mice caused a significant decrease in body weight (25%, p < 0.01) and thymus weight (34%, p < 0.001) as compared to controls suggesting the general toxic effect of the arsenic and could be associated with decreased food consumption and water intake. Co-treatment with arsenic and amla increased the body weight (21%, p < 0.05) and thymus weight (26%, p < 0.05) as compared to mice treated with arsenic alone. No significant effect on body weight and thymus weight was observed in mice treated with amla alone as compared to controls (Table 1).

Table 1.

Effect on body, thymus weight and thymus cellularity in mice exposed to arsenic, amla and their co-treatment for 30 days

Parameters
Control
Treatment groups
 
 
Arsenic
Amla
Amla
    (3 mg/kg) (500 mg/kg) + Arsenic
Body weight (g)
19.40 ± 1.12
15.40 ± 0.97*a
19.80 ± 0.80
18.60 ± 1.16*b
Thymus weight (mg)
79.2 ± 3.73
52.2 ± 3.26*a
77.6 ± 3.29
66.2 ± 4.54*b
Thymus cellularity (×10)-6 32.3 ± 6.60 26.2 ± 5.30*a 33.1 ± 5.20 30.6 ± 4.80*b

Values are mean ± SEM of five animals in each group.

*a-compared to control group; *b-compared to arsenic treated group.

*Significantly differs (p < 0.05).

Effect on cell viability in thymus of mice

Effect of arsenic and co-treatment of arsenic and amla on cell viability in thymus has been presented in Figure 2. Mice exposed to arsenic exhibited a significant decrease in cell viability (34%, p < 0.001) as compared to controls. Co-treatment with arsenic and amla increased the cell viability (21%, p < 0.01) in thymus as compared to those treated with arsenic alone. No significant effect on cell viability was observed in mice treated with amla alone as compared to controls (Figure 2).

Figure 2.

Figure 2

Effect of arsenic, amia and their co-treatment on cell viability in thymus of mice. Values are mean ± SEM of five animals in each group a-compared to control group, b-compared to arsenic treated group *Significantly differs (p < 0.05).

Effect on the lipid peroxidation in thymus of mice

To assess the level of oxidative damage to the biological membrane, effect of arsenic and co-treatment of arsenic and amla on lipid peroxidation in thymus has been carried out and presented in Figure 3. A significant increase in lipid peroxidation (52%, p < 0.001) in thymus was observed in mice exposed to arsenic as compared to controls. Co-treatment with arsenic and amla decreased in the level of lipid peroxidation (36%, p < 0.001) in thymus as compared to those treated with arsenic alone. No significant effect on the level of lipid peroxidation was observed in mice treated with amla alone as compared to controls (Figure 3).

Figure 3.

Figure 3

Effect of arsenic, amla and their co-treatment on the levels of lipid peroxidation in thymus of mice. Values are mean ± SEM of five animals in each group a-compared to control group, b-compared to arsenic treated group *Significantly differs (p < 0.05).

Effect on the reduced glutathione levels in thymus of mice

Arsenic has high affinity to GSH and thus enhances vulnerability towards oxidative stress. Figure 4 indicates the effect of arsenic and co-treatment of arsenic and amla on reduced glutathione levels in thymus of mice. Exposure to arsenic in mice caused a significantly decreased in the levels of reduced glutathione (34%, p < 0.001) in thymus as compared to controls. Co-treatment with arsenic and amla increase the levels of reduced glutathione (49%, p < 0.001) in thymus of mice as compared to those treated with arsenic alone. No significant effect on the levels of reduced glutathione was observed in the thymus of mice treated with amla alone as compared to controls (Figure 4).

Figure 4.

Figure 4

Effect of arsenic, amla and their co-treatment on the levels of reduced glutathione levels in thymus of mice. Values are mean ± SEM of five animals in each group a-compared to control group, b-compared to arsenic treated group *Significantly differs (p < 0.05).

Effect on the activity of superoxide dismutase in thymus of mice

Effect of arsenic and co-treatment of arsenic and amla on the activity of superoxide dismutase in thymus has been presented in Figure 5. The activity of superoxide dismutase, an enzyme involved in the dismutation of superoxide radicals, was found to be significant decreased (31%, p < 0.01) in thymus of mice exposed to arsenic as compared to controls. Co-treatment with arsenic and amla increased the activity of superoxide dismutase (36%, p < 0.05) in thymus as compared to those treated with arsenic alone. No significant effect on the activity of superoxide dismutase was observed in the thymus of mice treated with amla alone as compared to controls (Figure 5).

Figure 5.

Figure 5

Effect of arsenic, amla and their co-treatment on the activity of superoxide dismutase in thymus of mice. Values are mean ± SEM of five animals in each group a-compared to control group, b-compared to arsenic treated group *Significantly differs (p < 0.05).

Effect on the activity of catalase in thymus of mice

Effect of arsenic and co-treatment of arsenic and amla on the activity of catalase in thymus has been presented in Figure 6. Exposure to arsenic in mice caused a significant decrease the activity of catalase (35%, p < 0.05) in thymus of mice as compared to controls. Co-treatment with arsenic and amla increased the activity of catalase in thymus (32%, p < 0.05) as compared to those treated with arsenic alone suggesting a protective effect of amla against oxidative insult. No significant effect on the activity of catalase was observed in the thymus of mice treated with amla alone as compared to controls (Figure 6).

Figure 6.

Figure 6

Effect of arsenic, amla and their co-treatment on the catalase activity in thymus of mice. Values are mean ± SEM of five animals in each group a-compared to control group, b-compared to arsenic treated group *Significantly differs (p < 0.05).

Effect on caspase-3 activity in thymus of mice

Figure 7 demonstrate the effect of arsenic and co-treatment of arsenic and amla on the activity of caspase-3 in thymus of mice. Exposure to arsenic caused a significant increased in the caspase activity (2.42 fold, p < 0.001) in thymus of mice as compared to controls. Co-treatment with arsenic and amla decrease the activity of caspase (0.3 fold, p < 0.01) in thymus as compared to mice treated with arsenic alone suggesting a trend of recovery. No significant effect on the caspase activity was observed in mice treated with amla alone as compared to controls (Figure 7).

Figure 7.

Figure 7

Effect of arsenic, amla and their co-treatment on the catalase-3 activity in thymus of mice. Values are mean ± SEM of five animals in each group a-compared to control group, b-compared to arsenic treated group *Significantly differs (p < 0.05).

Effect on cytochrome c oxidase activity in thymus of mice

Effect of arsenic and co-treatment of arsenic and amla on the cytochrome c oxidase activity in thymus has been presented in Figure 8. Exposure of arsenic in mice showed a decreased cytochrome c oxidase activity (43%, p < 0.001) in thymus as compared to controls. Co-treatment with arsenic and amla increased the cytochrome c oxidase activity (62%, p < 0.001) in thymus as compared to mice treated with arsenic alone. No significant effect on the cytochrome c oxidase activity was observed in mice treated with amla alone as compared to controls (Figure 8).

Figure 8.

Figure 8

Effect of arsenic, amla and their co-treatment on the cytochrome c oxidase activity in thymus of mice. Values are mean ± SEM of five animals in each group a-compared to control group, b-compared to arsenic treated group *Significantly differs (p < 0.05).

Effect on the generation of ROS in thymus of mice

Arsenic has been found to be associated with the increased generation of ROS. Effect of arsenic and co-treatment of arsenic and amla on ROS generation in thymus has been presented in Figure 9. Exposure of arsenic to mice caused an increased generation of ROS (90%, p < 0.01) in thymus as compared to controls. Co-treatment with arsenic and amla decreased the ROS generation (52%, p < 0.01) in thymus as compared to mice treated with arsenic alone suggested the antioxidant and free radical scavenging activity of amla. No significant effect on the production of ROS was observed in mice treated with amla alone as compared to controls (Figure 9).

Figure 9.

Figure 9

Effect of arsenic, amla and their co-treatment on the generation of reactive oxygen species in thymocytes of mice. Cells were incubated with DCFH-DA and fluorescence was measured using a flow cytometer with FL-1 filter. Values are presented as mean ± SEM of three assays performed independently a-compared to control group, b-compared to arsenic treated group *Significantly differs (p < 0.05).

Effect on the mitochondrial membrane depolarization in thymus of mice

Effect of arsenic and co-treatment of arsenic and amla on mitochondrial membrane depolarization in thymus has been presented in Figure 10. Exposure of arsenic in mice showed decrease mitochondrial membrane depolarization (53%, p < 0.001) in thymus as compared to controls. Co-treatment with arsenic and amla increased the mitochondrial membrane depolarization (43%, p < 0.05) in thymus as compared to mice treated with arsenic alone. No significant effect on the mitochondrial membrane depolarization was observed in mice treated with amla alone as compared to controls (Figure 10).

Figure 10.

Figure 10

Effect of arsenic, amla and their co-treatment on mitochondrial membrane potential of thymocytes of mice. Cells were incubated with Rh 123 and fluorescence was measured using flow cytometer with FL-1 filter. Values are presented as mean ± SEM of three assays performed independently a-compared to control group, b-compared to arsenic treated group *Significantly differs (p < 0.05).

Effect on the cell cycle in thymus of mice

Cell cycle represents the DNA damage in cells in sub G1 peak. Figure 11 demonstrate the effect of arsenic and co-treatment of arsenic and amla on the DNA damage as observed by a sub G1 peak in thymus. Exposure of arsenic to mice caused an increased number of sub G1 peak indicating the DNA damage (21.37%, p < 0.01) in thymus as compared to controls. Co-treatment with arsenic and amla reduced the number of cells in sub G1 peak (11.67%, p < 0.01) in thymus as compared to mice treated with arsenic alone. No significant effect on the cell cycle was observed in mice treated with amla alone as compared to controls (Figure 11).

Figure 11.

Figure 11

Effect of arsenic, amla and their co-treatment on the cell cycle progression of thymocytes of mice. Control and amla treated cells showed no sub-G1 peak while arsenic showed high numbers of cells in sub-G1 peak and group co-treated with of arsenic and amla showed reduce number of cells in sub-G1 peaks as compared to arsenic. Cells were incubated with propidium iodide and flourescence was measured using flow cutometer with FL-2 filter. Values are presented in the historam as mean ± SEM of three assays performed independently representing sub-G1 population of cells.

Effect on the annexin V/PI binding assay in thymus of mice

Annexin binding assay has been used to measure the number of apoptosis and necrotic cells. Effect of arsenic and co-treatment of arsenic and amla on the apoptosis in thymus has been presented in Figure 12. Exposure of arsenic in mice caused an increased number of necrotic (9%) and apoptotic cells (11.52%) in thymus as compared to controls. Co-treatment with arsenic and amla decreased the number of necrotic (2.03%) and apoptotic cells (3.34%) in thymus as compared to mice treated with arsenic alone. No significant effect of apoptosis and necrosis in cells of the thymus was observed in mice treated with amla alone as compared to controls (Figure 12).

Figure 12.

Figure 12

Effect of arsenic, amla and their co-treatment on the annexin-V/PI dual staining of thymocytes of mice. Cells in the upper right (UR) portion are late apoptotic cells, upper left (UL) are necrotic cells whereas cells in the lower left (LL) and lower right (LR) portion are viable and early apoptotic cells respectively. Values are presented as mean ± SEM of three assays performed independently.

Discussion

Enhanced oxidative stress has been found to play a crucial role in the induction of apoptosis under both pathological and physiological conditions. Increased generation of free radicals associated with enhanced oxidative stress has been found to be implicated in arsenic induced thymic atrophy [20,21]. Numerous studies have reported that exposure to arsenic increased the production of free radical generation and cause oxidative damage to the biological membrane through increased levels of lipid peroxidation, protein carbonyl contents followed by decreased antioxidant defense system [20,21,28]. GSH is an important biomolecule involve in the antioxidant defense system against toxicants. The decrease in the levels of GSH following exposure to arsenic has been found to be associated with high affinity of arsenic with GSH [51]. Chronic arsenic exposure has largely been associated with the apoptosis in the lymphocytes and involve in immunotoxic response. Viability of cells has been found to be decreased in thymus of mice following exposure to arsenic as observed in the present study suggested the immunotoxicity of arsenic. Increased production of ROS associated with enhanced lipid peroxidation and decreased levels of reduced glutathione, the activity of superoxide dismutase and catalase as observed in the present study consistent with the earlier findings [20,21]. Most of the toxic chemicals directly act on the mitochondria, disrupt its phospholipids membrane and cause mitochondrial dysfunctions [2,52,53]. Arsenic compounds have been shown to be strong inducers of apoptosis in normal and transformed cells through production of ROS [54], decreased mitochondrial membrane potential [52], activation of caspases [25,55], increased fragmentation of DNA [55], decreased expression of anti-apoptotic proteins (Bcl-2, Bcl-XL) and increased expression of pro-apoptotic proteins [55]. Martin-Chouly et al. [56] reported that inorganic arsenic directly acts on human T-cells and impaired their activity via up-regulation of several immune and stress response genes. However, the inhibition of T cell proliferation was independently of heme oxygenase −1 expression and monocyte related accessory signals [56]. Exposure to arsenic through semiconductor elements including indium arsenide and gallium arsenide could induce alterations in gene expression and immune response associated with increased production of ROS which might be involved in the apoptosis and necrosis in T-lymphocytes and neuronal cells [57,58]. A decreased in the activity of cytochrome c oxidase, mitochondrial membrane potential and increased activity of mitochondrial caspase-3, number of cells in sub G1 peak and number of apoptotic and necrotic cells following exposure to arsenic in mice as observed in the present study is consistent with the earlier reports.

Experimental studies have reported that weight of organs (thymus, spleen, adrenals) responsible for immune response was decreased following exposure to arsenic [20,59]. Subchronic low-level exposure to arsenic may affect immune responses [59]. Decrease body weight in experimental animals exposed to arsenic has been reported [59-61]. Decrease in the body weight indicates the general toxic effect of the chemical. A decrease in the body weight and thymus weight as observed in the present study could be due to immunotoxic response of arsenic that have been found to be recovered by co-treatment with amla and arsenic in mice.

Various pharmacological preparations and plant extracts are reported to have strong antioxidant potential and used against arsenic induced oxidative damage to investigate their protective efficacy [2,21,30]. Phyto constituents including flavanoids found in the plant extracts are effective as radical scavengers and inhibitors of lipid peroxidation [61-63]. Amla contains a wide variety of phenolics and its derivatives associated with its strong antioxidant potential. Amla is widely accepted immune booster among the people since it possesses multiple pharmacological and immunomodulatory properties [21,30-33]. It has been reported that amla protects against the harmful action of free radicals and exhibit its ameliorating effects in biological system [32,33]. Sharma et al. [21] reported that the antioxidant potential of amla may be due to the presence of the many phyto-constituents, which provide maximum conjugation with free radical species, thus reducing the number of free radicals available and the extent of cellular damage. They further suggested that pre and post supplementation of fruit extract of amla significantly reduce arsenic induced oxidative stress in the liver as a result serum transaminases and MDA content become lowered in the liver and also increased activity of superoxide dismutase, catalase, glutathione S transferase and serum alkaline phosphatase activities [21]. Reddy et al. [64] reported that alcohol-induced oxidative stress in plasma of rats could be ameliorated through the amla that could be due to the combined effect of phytophenols present in it. In another study, Kumar et al. [65] found that amla significantly protects against lead induced toxicity by decrease generation of free radicals in one day old male broiler chicks. Haque et al. [66] suggested that amla extract was very effective in reducing cyclophosphamide induced suppression of humoral immunity in mice. They also reported that amla extract treatment in normal animals could modulate levels of certain antioxidants of kidney and liver resulted in restoration of antioxidant enzymes in cyclophosphamide treated animals and further suggested that amla or its medicinal preparations may be useful in combination therapy in cancer patients. The supplementation with Triphala (Terminalia chebula, Terminalia belerica and Emblica officinalis) prevents the noise-stress induced changes in the antioxidant as well as cell-mediated immune response in rats [67]. Enhanced lipid peroxidation and decreased levels of reduced glutathione, activity of superoxide dismutase and catalase following exposure to arsenic has been found to be protected following simultaneous treatment with arsenic and amla in mice suggesting protective efficacy of amla.

In the present study, treatment with amla alone had no significant effect on cell viability, lipid peroxidation, levels of reduced glutathione, the activity of superoxide dismutase, Catalase and other apoptotic markers including the activity of caspase–3 and cytochrome c oxidase. However, decreased cell viability has been found to be protected following co-treatment with arsenic and amla in thymus of mice. Also, increased levels of lipid peroxdation, activity of caspase-3 and decreased levels of reduced glutathione, activity of superoxide dismutase, catalase and activity of cytochrome c oxidase following arsenic exposure were protected in mice co-treated with arsenic and amla. Such an immunoprotective effect of amla may attribute to its antioxidant potential to counteract free radicals and prevented from enhanced oxidative stress. The fruit extract of amla has been reported to enhance cyto-protection, decrease apoptosis and DNA fragmentation [68,69]. It has also been found to protect against heavy metals induced clastogenicity [70]. Chromium (VI) induced free radical generation associated with enhanced oxidative stress has been found to protected following treatment with amla [30]. Further, chromium (VI) induced apoptosis, DNA fragmentation and immunosuppressive effects on lymphocyte proliferation has been ameliorated following treatment with amla and it also restored the altered levels IL-2 and γ-IFN [30]. Decreased activity of cytochrome c oxidase, mitochondrial membrane potential and increased activity of mitochondrial caspase-3, number of cells in sub G1 peak and number of apoptotic and necrotic cells in arsenic exposed mice have also been found to be protected following simultaneous treatment with arsenic and amla in the present study.

Conclusions

In conclusion, the results of the present study clearly indicated that arsenic induced free radical generation and enhance oxidative stress leading to apoptosis in thymocytes of mice. Arsenic induced decrease mitochondrial membrane potential has been found to increased following co-treatment with arsenic and amla. Further, increased number of apoptosis, necrotic cells and DNA damage following exposure to arsenic has also been found to be decreased following co-treatment with arsenic and amla indicates the anti-apoptotic property of amla that could be due to its strong antioxidative potential. Although the results of the present study exhibit immunomodulatory effects of amla through its antioxidant properties, further studies are required to understand the detailed mechanism of immunoprotection.

Competing interests

The authors declare that they have no financial or personnel competing interests.

Authors’ contributions

MS: designed the experiment; MS and SY conducted research and drafting of the manuscript; VS: acquisition of data; analysis and interpretation of data; statistical analysis; SK: review of the manuscript; analysis and interpretation of data; obtained funding; administrative support; study supervision. All authors read and approved the final manuscript.

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1472-6882/13/193/prepub

Contributor Information

Manish K Singh, Email: manishbiochem2016@gmail.com.

Suraj S Yadav, Email: surajsy81@gmail.com.

Vineeta Gupta, Email: icon.venus16@gmail.com.

Sanjay Khattri, Email: drskhattri01@gmail.com.

Acknowledgement

The authors thank to Head, Department of Pharmacology, King George Medical University, Lucknow for his interest in the study. The authors are also thankful to Dr. P.C. Choudhury, Professor, Government Ayurvedic College and Hospital, Lucknow. Manish Kumar Singh is grateful to the Indian Council of Medical Research, New Delhi for the award of research fellowship. The technical support by Mr. Veerendra Kumar Saini is also acknowledged.

References

  1. Das AK, Bag S, Sahu R, Dua TK, Sinha MK, Gangopadhyay M. et al. Protective effect of Corchorus olitorius leaves on sodium arsenite-induced toxicity in experimental rats. Food Chem Toxicol. 2010;48:326–335. doi: 10.1016/j.fct.2009.10.020. [DOI] [PubMed] [Google Scholar]
  2. Flora SJS. Arsenic-induced oxidative stress and its reversibility. Free Rad Biol Med. 2011;51:257–281. doi: 10.1016/j.freeradbiomed.2011.04.008. [DOI] [PubMed] [Google Scholar]
  3. Chaineau E, Binet S, Pol D, Chatellier G, Meininger V. Embryotoxic effects of sodium arsenite and sodium arsenate on mouse embryos in culture. Teratology. 1990;41:105–112. doi: 10.1002/tera.1420410111. [DOI] [PubMed] [Google Scholar]
  4. Chiou HY, Huang WI, Su C, Chang SF, Hsu YH, Chen CJ. Dose response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke. 1997;28:1717–1723. doi: 10.1161/01.STR.28.9.1717. [DOI] [PubMed] [Google Scholar]
  5. Rodriguez VM, Carrizales L, Jimenez-Capdeville MF, Dufour L, Giordano M. The effects of sodium arsenite exposure on behavioral parameters in the rat. Brain Res Bull. 2001;55:301–308. doi: 10.1016/S0361-9230(01)00477-4. [DOI] [PubMed] [Google Scholar]
  6. WHO. Arsenic and arsenic compounds. Inter-organization programme for the sound management of chemicals. 2nd ed. Environmental health criteria 224. Geneva: World Health Organization; 2001. [Google Scholar]
  7. Del Razo LM, Garcia-Vargas GG, Garcia-Salcedo J, Sanmiguel MF, Rivera M, Hernandez MC, Cebrian ME. Arsenic levels in cooked food and assessment of adult dietary intake of arsenic in the Region Lagunera, Mexico. Food Chem Toxicol. 2002;40:1423–1431. doi: 10.1016/S0278-6915(02)00074-1. [DOI] [PubMed] [Google Scholar]
  8. Rahman M. Arsenic and contamination of drinking water in Bangladesh: a public health perspective. J Health Popul Nutr. 2002;20:193–197. [PubMed] [Google Scholar]
  9. Kapaj S, Peterson H, Liber K, Bhattacharya P. Human health effects from chronic arsenic poisoning—a review. J. Environ. Sci Health. 2006;41:2399–2428. doi: 10.1080/10934520600873571. [DOI] [PubMed] [Google Scholar]
  10. Andrew AS, Jewell DA, Mason RA, Whitfield ML, Moore JH, Karagas MR. Drinking-water arsenic exposure modulates gene expression in human lymphocytes from a U.S. population. Environ Health Perspect. 2008;116:524–531. doi: 10.1289/ehp.10861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bolt AM, Byrd RM, Klimecki WT. Autophagy is the predominant process induced by arsenite in human lymphoblastoid cell lines. Toxicol Appl Pharmacol. 2010;244:366–373. doi: 10.1016/j.taap.2010.01.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bolt AM, Douglas RM, Klimecki WT. Arsenite exposure in human lymphoblastoid cell lines induces autophagy and coordinated induction of lysosomal genes. Toxicol Lett. 2010;30:153–159. doi: 10.1016/j.toxlet.2010.08.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Banerjee N, Nandy S, Kearns JK, Bandyopadhyay AK, Das JK, Majumdez P, Basu S, Banerjee S, Sau TJ, States JC, Giri AK. Polymorphisms in the TNF-and alpha; and IL10-gene promoters and risk of arsenic-induced skin lesions and other non-dermatological health effects. Toxicol Sci. 2011;Feb 25 doi: 10.1093/toxsci/kfr046. [Epub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Raqib R, Ahmed S, Sultana R, Wagatsuma Y, Mondal D, Hoque AM, Nermell B, Yunus M, Roy S, Persson LA, Arifeen SE, Moore S, Vahter M. Effects of in utero arsenic exposure on child immunity and morbidity in rural Bangladesh. Toxicol Lett. 2009;185:197–202. doi: 10.1016/j.toxlet.2009.01.001. [DOI] [PubMed] [Google Scholar]
  15. Moore SE, Prentice AM, Wagatsuma Y, Fulford AJ, Collinson AC, Raqib R, Vahter M, Persson LA, Arifeen SE. Early-life nutritional and environmental determinants of thymic size in infants born in rural Bangladesh. Acta Paediatr. 2009;98:1168–1175. doi: 10.1111/j.1651-2227.2009.01292.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Escobar J, Varela-Nallar L, Coddou C, Nelson P, Maisey K, Valdes D, Aspee A, Espinosa V, Rozas C, Montoya M, Mandiola C, Rodríguez FE, Acuna-Castillo C, Escobar A, Fernández R, Diaz H, Sandoval M, Imarai M, Rios M. Oxidative damage in lymphocytes of copper smelter workers correlated to higher levels of excreted arsenic. Mediators Inflamm. 2010;2010:403830. doi: 10.1155/2010/403830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ahmed S, Mahabbat-e Khoda S, Rekha RS, Gardner RM, Ameer SS, Moore S, Ekstrom EC, Vahter M, Raqib R. Arsenic-associated oxidative stress, inflammation, and immune disruption in human placenta and cord blood. Environ Health Perspect. 2011;119:258–264. doi: 10.1289/ehp.1002086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rahman M, Axelson O. Diabetes-mellitus and aqrsenic exposer-a second look at case controldata from a Swedish copper smelter. Occup Environ Med. 1995;52:773–774. doi: 10.1136/oem.52.11.773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kitchin KT. Recent advances in arsenic carcinogenesis: modes of action, animals model system, and methylated arsenic metabolites. Toxicol Appl Pharmacol. 2001;172:249–261. doi: 10.1006/taap.2001.9157. [DOI] [PubMed] [Google Scholar]
  20. Stepnik M, Stanczyk M, Arkusz J, Lewinska D. Assessment of apoptosis in thymocytes and splenocytes from mice exposed to arsenate in drinking water: cytotoxic effects of arsenate on the cells in vitro. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2005;40:369–84. doi: 10.1081/ESE-200045629. [DOI] [PubMed] [Google Scholar]
  21. Sharma A, Sharma MK, Kumar M. Modulatory role of Emblica officinalis fruit extract against arsenic induced oxidative stress in swiss albino mice. Chemico-Biol Interaction. 2009;180:20–30. doi: 10.1016/j.cbi.2009.01.012. [DOI] [PubMed] [Google Scholar]
  22. Schaumloffel N, Gebel T. Heterogeneity of the DNA damage provoked by antimony and arsenic. Mutagenesis. 1998;13:281–286. doi: 10.1093/mutage/13.3.281. [DOI] [PubMed] [Google Scholar]
  23. Mukherjee S, Roy M, Dey S, Bhattacharya RK. A mechanistic approach for modulation of arsenic toxicity in human lymphocytes by curcumin, an active constituent of medicinal herb Curcuma longa Linn. J. Clin. Biochem. Nutr. 2007;41:32–42. doi: 10.3164/jcbn.2007005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ramirez P, Del Razo LM, Gutierrez-Ruiz MC, Gonsebatt ME. Arsenite induces DNA-protein crosslinks and cytokeratin expression in the WRL-68 human hepatic cell line. Carcinogenesis. 2000;21:701–706. doi: 10.1093/carcin/21.4.701. [DOI] [PubMed] [Google Scholar]
  25. Li D, Morimoto K, Takeshita T, Lu Y. Formamidopyrimidine- DNA glycosylase enhances arsenic-induced DNA strand breaks in PHA-stimulated and unstimulated human lymphocytes. Environ Health Perspect. 2001;109:523–526. doi: 10.1289/ehp.01109523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Abernathy CO, Liu YP, Longfellow D, Aposhian HV, Fowler B, Goyer R, Menzer R, Rossman T, Thompson C, Walkes M. Arsenic: health effects, mechanisms of actions and research issues. Environ Health Perspect. 1999;107:593–597. doi: 10.1289/ehp.99107593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Basu A, Mahata J, Gupta S, Giri AK. Genetic toxicology of a paradoxical human carcinogen, arsenic: a review. Mutat Res. 2001;488:171–194. doi: 10.1016/S1383-5742(01)00056-4. [DOI] [PubMed] [Google Scholar]
  28. Yadav RS, Sankhwar ML, Shukla RK, Chandra R, Pant AB, Islam F, Khanna VK. Attenuation of arsenic neurotoxicity by curcumin in rats. Toxicol Appl Pharmacol. 2009;240:367–376. doi: 10.1016/j.taap.2009.07.017. [DOI] [PubMed] [Google Scholar]
  29. Yadav RS, Sankhwar ML, Shukla RK, Chandravanshi LP, Ansari RW, Shukla PK, Pant AB, Khanna VK. Neuroprotective efficacy of curcumin in arsenic induced cholinergic dysfunctions in rats. Neurotoxicology. 2011;32:760–768. doi: 10.1016/j.neuro.2011.07.004. [DOI] [PubMed] [Google Scholar]
  30. Sai Ram M, Neetu D, Yogesh B, Anju B, Dipti P, Pauline T, Sharma SK, Sarada SK, Ilavazhagan G, Kumar D, Selvamurthy W. Cyto-protectiveand immunomodulating properties of Amla (Emblica officinalis) on lymphocytes: an in-vitro study. J Ethnopharmacol. 2002;81:5–10. doi: 10.1016/S0378-8741(01)00421-4. [DOI] [PubMed] [Google Scholar]
  31. Khandelwal S, Shukla LJ, Shanker R. Modulation of acute Cadmium toxicity by by Emblica officinalis fruit in rat. Exp Bio. 2002;40:564–570. [PubMed] [Google Scholar]
  32. Poltanov EA, Shikov AN, Dorman HJD, Pozharitskaya ON, Makarov VG, Tikhonov VP. et al. Chemical and antioxidant evaluation of Indian gooseberry (Emblica officinalis Gaertn., syn. Phyllanthus emblica L.) supplements. J Phytotherapy Res. 2009;23:1309–1315. doi: 10.1002/ptr.2775. [DOI] [PubMed] [Google Scholar]
  33. Sreeramulu D, Raghunath M. Antioxidant activity and phenolic content of roots, tubers and vegetables commonly consumed in India. Food Res Int. 2009;43:1017–1020. [Google Scholar]
  34. Adams LS, Seeram NP, Aggarwal BB, Takada YS, Heber D. Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J Agri Food Chem. 2006;54:980–985. doi: 10.1021/jf052005r. [DOI] [PubMed] [Google Scholar]
  35. Institoris L, Siroki O, Undeger U, Basaran N, Desi I. Immunotoxicological investigation in rats dosed repeatedly with combinations of cypermethrin, As (III), and Hg(II) Toxicology. 2002;172:59–67. doi: 10.1016/S0300-483X(01)00589-3. [DOI] [PubMed] [Google Scholar]
  36. El-Demerdash FM, Yousef MI, Radwan FM. Ameliorating effect of curcumin on sodium arsenite-induced oxidative damage and lipid peroxidation in different rat organs. Food Chem Toxicol. 2009;47:249–254. doi: 10.1016/j.fct.2008.11.013. [DOI] [PubMed] [Google Scholar]
  37. Liu X, Cui C, Zhao M. et al. Identification of phenolics in the fruit of emblica (Phyllanthus emblica L.) and their antioxidant activities. Food Chem. 2008;109:909–915. doi: 10.1016/j.foodchem.2008.01.071. [DOI] [PubMed] [Google Scholar]
  38. Luo W, Zhao M, Yang B, Shen G, Rao G. Idntification of bioactive compounds in Phllenthus emblica L. fruit and their free radical scavenging activities. Food Chem. 2009;114:499–504. doi: 10.1016/j.foodchem.2008.09.077. [DOI] [Google Scholar]
  39. Yang B, Zhao MM, Prasad KN, Jiang GX, Jiang YM. Effect of methylation on the structure and radical scavenging activity of polysaccharides from longan (Dimocarpus longan Lour.) fruit pericarp. Food Chem. 2010;118:364–368. doi: 10.1016/j.foodchem.2009.04.128. [DOI] [Google Scholar]
  40. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1988;65:55–63. doi: 10.1016/0022-1759(83)90303-4. [DOI] [PubMed] [Google Scholar]
  41. Ohkawa H, Osishi N, Yagi K. Assay for lipid peroxide in animal tissue by thiobarbituric acid reaction. Anal Biochem. 1979;251:351–358. doi: 10.1016/0003-2697(79)90738-3. [DOI] [PubMed] [Google Scholar]
  42. Moron MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta. 1979;582:67–78. doi: 10.1016/0304-4165(79)90289-7. [DOI] [PubMed] [Google Scholar]
  43. Marklund S, Marklund G. Involvement of superoxide anion radical in auto oxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974;47:469–474. doi: 10.1111/j.1432-1033.1974.tb03714.x. [DOI] [PubMed] [Google Scholar]
  44. Aebi H. In: Methods in Enzymology, Volume 105. Packer L, editor. 1984. Catalase in vitro; pp. 121–126. (Academic Press, New York). [DOI] [PubMed] [Google Scholar]
  45. Pathak N, Khandelwal S. Immunomodulatory role of piperine in cadmium induced thymic atrophy and spleenomegaly in mice. Environ Toxicol Pharmacol. 2009;28:52–60. doi: 10.1016/j.etap.2009.02.003. [DOI] [PubMed] [Google Scholar]
  46. Paglia DE, Valentine WM. Studies on the qualitative and quantitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158–169. [PubMed] [Google Scholar]
  47. Bai J, Rodriquez AM, Melendez JA, Cederbaum AI. Over expression of catalase in Cytosolic or mitochondrial compartment protects HepG2 cells against oxidative injury. J Biochem. 1999;274:26217–24. doi: 10.1074/jbc.274.37.26217. [DOI] [PubMed] [Google Scholar]
  48. Darzynkiewicz Z, Juan G, Li X, Gorczca W, Murakami T, Traganos F. Cytometry in cells necrobiology: analysis of apoptosis and accidental cell death (necrosis) Cytometry. 1997;27:1–20. doi: 10.1002/(SICI)1097-0320(19970101)27:1&#x0003c;1::AID-CYTO2&#x0003e;3.0.CO;2-L. [DOI] [PubMed] [Google Scholar]
  49. Vermes I, Haanen C, Steffens-Nakken H, Recutelings-Perger C. Anovel assay for apoptosis, flow cytometric detetion of phosphatidy/serine expression on early apoptotic cells using fluorescein-labeled Annexin V. J Immunol method. 1995;184:39–44. doi: 10.1016/0022-1759(95)00072-I. [DOI] [PubMed] [Google Scholar]
  50. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:263–275. [PubMed] [Google Scholar]
  51. Gupta R, Flora SJ. Effect of Centella asiatica on arsenic induced oxidative stress and metal distribution in rats. J Applied Toxicol. 2006;26:213–222. doi: 10.1002/jat.1131. [DOI] [PubMed] [Google Scholar]
  52. Banerjee N, Banerjee M, Ganguly S, Bandyopadhyay S, Das JK, Bandyopadhay A, Chatterjee M, Giri AK. Arsenic-induced mitochondrial instability leading to programmed cell death in the exposed individuals. Toxicology. 2008;246:101–111. doi: 10.1016/j.tox.2007.12.029. [DOI] [PubMed] [Google Scholar]
  53. Majumdar S, Karmakar S, Maiti A, Choudhury M, Ghosh A, Das AS, Mitra C. Arsenic-induced hepatic mitochondrial toxicity in rats and its amelioration by dietary phosphate. Environ Toxicol Pharmacol. 2011;31:107–118. doi: 10.1016/j.etap.2010.09.011. [DOI] [PubMed] [Google Scholar]
  54. Maeda H, Hori S, Nishitoh H, Ichijo H, Ogawa O, Kakehi Y, Kakizuka A. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer. Cancer Res. 2001;61:5432–5440. [PubMed] [Google Scholar]
  55. Hossain K, Akhand AA, Kato M, Du J, Takeda K, Wu J, Takeuchi K, Liu W, Suzuki H, Nakashima I. Arsenite induces apoptosis of murine T lymphocytes through membrane raft-linked signaling for activation of c-Jun amino-terminal kinase. J Immunol. 2000;165:4290–4297. doi: 10.4049/jimmunol.165.8.4290. [DOI] [PubMed] [Google Scholar]
  56. Martin-Chouly C, Morzadec C, Bonvalet M, Galibert MD, Fardel O, Vernhet L. Inorganic arsenic alters expression of immune and stress response genes in activated primary human T lymphocytes. Mol Immunol. 2011;48:956–965. doi: 10.1016/j.molimm.2011.01.005. [DOI] [PubMed] [Google Scholar]
  57. Bustamante J, Dock L, Vahter M, Fowler B, Orrenius S. The semiconductor elements arsenic and indium induce apoptosis in rat thymocytes. Toxicology. 1997;118:129–136. doi: 10.1016/S0300-483X(96)03607-4. [DOI] [PubMed] [Google Scholar]
  58. Flora SJS, Bhatt K, Mehta A. Arsenic moiety in gallium arsenide is responsible for neurona apoptosis and behavioral alterations in rats. Toxicol Appl Pharmacol. 2009;240:236–244. doi: 10.1016/j.taap.2009.05.013. [DOI] [PubMed] [Google Scholar]
  59. Schulz H, Nagymajtényi L, Institoris L, Papp A, Siroki O. A study on behavioral, neurotoxicological, and immunotoxicological effects of sub-chronic arsenic treatment in rats. J Toxicol Environ Health A. 2002;65:1181–1193. doi: 10.1080/152873902760125390. [DOI] [PubMed] [Google Scholar]
  60. Karim MR, Haque A, Islam K, Ali N, Salam KA, Saud ZA, Hossain E, Fajol A, Akhand AA, Himeno S, Hossain K. Protective effects of the dietary supplementation of turmeric (Curcuma longa L.) on sodium arsenite-induced biochemical perturbation in mice. Bangladesh Med Res Counc Bull. 2010;36:82–88. doi: 10.3329/bmrcb.v36i3.7287. [DOI] [PubMed] [Google Scholar]
  61. Ferreira M, Matos RC, Oliveira H, Nunes B, Pereira MD. Impairment of mice spermatogenesis by sodium arsenite. Hum Exp Toxicol. 2011;Apr 13 doi: 10.1177/0960327111405862. [Epub ahead of print] [DOI] [PubMed] [Google Scholar]
  62. Yildirim A, Oktay M, Bulaloulu V. The antioxidant activity of the leaves of Cydonia vulgaris. Turkish J Med Sci. 2001;31:23–27. [Google Scholar]
  63. Dash DK, Yeligar VC, Nayak SS, Ghosh T, Rajalingam D, Sengupta P, Maiti BC, Maity T. Evaluation of hepatoprotective and antioxidant activity of Ichnocarpus frutescens (Linn.) R.Br. on paracetamol-induced hepatotoxicity in rats. Trop J Pharmaceu Res. 2007;6:755–765. [Google Scholar]
  64. Reddy VD, Padmavathi P, Paramahamsa M, Varadacharyulu NC. Amelioration of alcohol-induced oxidative stress by Emblica officinalis (amla) in rats. Indian J Biochem Biophys. 2010;47:20–25. [PubMed] [Google Scholar]
  65. Kumar MR, Reddy AG, Anjaneyulu Y, Reddy GD. Oxidative stress induced by lead and antioxidant potential of certain adaptogens in poultry. Toxicol Int. 2010;17:45–48. doi: 10.4103/0971-6580.72668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Haque R, Bin-Hafeez B, Ahmad I, Parvez S, Pandey S, Raisuddin S. Protective effects of Emblica officinalis Gaertn in cyclophosphamide-treated mice. Hum Exp Toxicol. 2001;20:643–650. doi: 10.1191/096032701718890568. [DOI] [PubMed] [Google Scholar]
  67. Srikumar R, Parthasarathy NJ, Manikandan S, Narayanan GS, Sheeladevi R. Effect of Triphala on oxidative stress and on cell-mediated immune response against noise stress in rats. Mol Cell Biochem. 1996;283:67–74. doi: 10.1007/s11010-006-2271-0. [DOI] [PubMed] [Google Scholar]
  68. Bhattacharya A, Chatterjee A, Ghosal S, Bhattacharya SK. Antioxidant activity of active tannoid principle of Emblica officinalis (Amla) Indian J Exp Biol. 1999;37:676–680. [PubMed] [Google Scholar]
  69. Bandyopadhyay SK, Pakrashi SC, Pakrashi A. The role of antioxidant activity of Phyllanthus emblica fruits on prevention from indomethacin induced gastric ulcer. J Ethnopharmacol. 2000;70:171–176. doi: 10.1016/S0378-8741(99)00146-4. [DOI] [PubMed] [Google Scholar]
  70. Roy AK, Dhir H, Sharma A. Modification of metal-induced micronuclei formation in mouse bone marrow erythrocytes by Phyllanthus fruit extract and ascorbic acid. Toxicol Lett. 1992;62:9–17. doi: 10.1016/0378-4274(92)90072-R. [DOI] [PubMed] [Google Scholar]

Articles from BMC Complementary and Alternative Medicine are provided here courtesy of BMC

RESOURCES